Capital International Investors 13D and 13G filings for Allogene Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | Allogene Therapeutics, Inc. ALLO | Capital International Investors | 1,728,252 1.200% | -5,971,451 (-77.55%) | Filing |
| 2021-02-16 4:04 pm Purchase | 2021-02-16 | 13G | Allogene Therapeutics, Inc. ALLO | Capital International Investors | 7,699,703 5.500% | 7,699,703 (New Position) | Filing |